IL-5 Is the Predominant Eosinophil-active Cytokine in the Antigen-induced Pulmonary Late-phase Reaction
- 1 April 1993
- journal article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 147 (4) , 901-907
- https://doi.org/10.1164/ajrccm/147.4.901
Abstract
The mechanism of airway eosinophilia during antigen-induced inflammation was investigated by measurement of eosinophil-active cytokines utilizing an eosinophil survival assay. In the first study, 4 patients with allergic rhinitis underwent segmental bronchoprovocation (SBP) with low, medium, and high doses of ragweed extract instilled into different bronchial subsegments; bronchoalveolar lavage (BAL) fluids were collected from each segment 12 min and 48 h after challenge. Eosinophil granule proteins and eosinophil survival activity were significantly elevated in the 48-h (late-phase) BAL fluids from these segments. Correlations were observed between the concentrations of eosinophil granule proteins and eosinophil survival activity (rs = 0.717 to 0.880, p < 0.001) in BAL fluids. Eosinophil survival activity was completely neutralized by anti-IL-5 monoclonal antibody in five of the seven 48-h samples tested representing three of the 4 patients. In the two remaining samples, eosinophil survival activity was only partially neutralized by either anti-IL-5 antibody or anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) but was completely neutralized by anti-IL-5 and anti-GM-CSF in combination. Subsequently, in the second study, 10 patients with allergic rhinitis were challenged by SBP with ragweed extract. Eosinophil survival activity was significantly elevated in the 48-h BAL fluids; this activity was partially neutralized by anti-IL-5 antibody about (48%) and completely neutralized by the combination of anti-IL-5 and anti-GM-CSF antibodies. These findings suggest that the eosinophil survival activity in the late inflammatory lesions following SBP with allergen is mainly associated with IL-5, with small contributions from GM-CSF. Thus, IL-5 is the predominant eosinophil-active cytokine present in BAL fluids during allergen-induced late-phase inflammation and may play a key role in the pathophysiology of allergen-induced, eosinophil-predominant airway inflammation.Keywords
This publication has 31 references indexed in Scilit:
- Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP.Journal of Clinical Investigation, 1991
- Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates.Journal of Clinical Investigation, 1991
- The eosinophil and bronchial asthma: Current understandingJournal of Allergy and Clinical Immunology, 1990
- Cellular Events in the Bronchi in Mild Asthma and after Bronchial ProvocationAmerican Review of Respiratory Disease, 1989
- Toxicity of Eosinophil Cationic Proteins for Guinea Pig Tracheal EpitheliumIn VitroAmerican Review of Respiratory Disease, 1989
- Late Asthmatic ResponsesAmerican Review of Respiratory Disease, 1987
- The eosinophil and the pathophysiology of asthmaJournal of Allergy and Clinical Immunology, 1986
- Eosinophils, bronchial hyperreactivity and late‐phase asthmatic reactionsClinical and Experimental Allergy, 1985
- The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease?Journal of Allergy and Clinical Immunology, 1982
- Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significanceJournal of Allergy and Clinical Immunology, 1981